SCARLETRED is honored to be recognized by ADVANTAGE AUSTRIA for our pioneering work in digital dermatology and AI-driven skin analysis. The feature highlights our patented imaging technology, CE-certified and clinically validated AI engine, and the growing global adoption of Scarletred®Vision across pharmaceutical, cosmetic, and clinical research applications.

Our standardized imaging system and AI analytics provide accurate, quantifiable, and remote skin assessment - supporting decentralized clinical trials, improving data quality, and accelerating therapeutic development. With the launch of our new AI agent Arora®, we are pushing the boundaries of dermatology innovation by detecting complex patterns, enabling rare disease analysis, and enhancing telemedicine solutions. The feature also highlights SCARLETRED’s international footprint including its U.S. presence near MIT, and its growing collaborations with global research leaders and multinational pharmaceutical companies.

Beyond this recognition, we continue to focus on what sets us apart: traditional skin-imaging workflows are often hardware-heavy and slow, but Scarletred®Vision leverages smartphones to simplify processes - delivering automation, precision, and scalable skin assessment that legacy devices cannot match.

Proudly redefining dermatology, Scarletred®Vision removes complexity in skin imaging, drives breakthroughs, and sets a global standard that empowers partners while advancing patient care.

📖 Read the full article:
https://www.advantageaustria.org/us/news/Scarletred.en.html

‍